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Abstract
The food enzyme considered in this opinion is aqualysin 1 (EC 3.4.21.111), produced from the
genetically modified strain Bacillus subtilis LMGS 25520 by Puratos NV. The production strain was not
detected in the food enzyme. Aqualysin 1 is intended to be used in baking processes. Based on the
maximum use level recommended and individual consumption data from the EFSA Comprehensive
European Food Consumption Database, dietary exposure to the food enzyme–total organic solids
(TOS) was estimated to be up to 2.13 mg TOS/kg body weight per day in European populations.
Genotoxicity tests indicated no genotoxic concerns. The allergenicity was evaluated by searching for
similarity of the amino acid sequence to those of known allergens and 23 matches were found
(20 respiratory and 3 dermal allergens). However, the Panel considered that there are no indications
for food allergic reactions to the food enzyme. The genetic modifications performed, the
manufacturing process, the compositional and biochemical data, the allergenicity and the genotoxicity
assessment did not raise safety concerns. The Panel considered the margin of exposure (MOE)
calculated from the no observed adverse effect level (NOAEL) determined from the repeated dose
90-day oral toxicity study and the estimated dietary exposure as insufficient to conclude that there is
no safety concern for this food enzyme under the intended conditions of use. The Panel noted that
recombinant DNA was present in all batches of the food enzyme tested.
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1. Introduction
Article 3 of the Regulation (EC) No 1332/20081 provides definitions for ‘food enzyme’ and ‘food
enzyme preparation’.
‘Food enzyme’ means a product obtained from plants, animals or micro-organisms or products
thereof obtained by a fermentation process using micro-organisms: (i) containing one or more
enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a
technological purpose at any stage of the manufacturing, processing, preparation, treatment,
packaging, transport or storage of foods.
‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which
substances such as food additives and/or other food ingredients are incorporated to maintain their
properties and facilitate their stability storage, sale, standardisation, dilution or dissolution.
Before January 2009, food enzymes other than those used as food additives were not regulated or
were only regulated as processing aids under the legislation of the Member States. On 20 January
2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to
enzymes that are added to food to perform a technological function for the manufacture, processing,
preparation, treatment, packaging, transport or storage of such food, including enzymes used as
processing aids. Regulation (EC) No 1331/20082 established European Union (EU) procedures for the
safety assessment and the authorisation procedure of food additives, food enzymes and food
flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that:
• it does not pose a safety concern to the health of the consumer at the level of use proposed,
• there is a reasonable technological need, and
• its use does not mislead the consumer.
All food enzymes currently on the EU market and intended to remain on that market, as well as all
new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority
(EFSA) and approval via an EU Community list.
The ‘Guidance on submission of a dossier on a food enzyme for evaluation’ (EFSA, 2009a) lays
down the administrative, technical and toxicological data required.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background as provided by the European Commission
Only food enzymes included in the Union list may be placed on the market as such and used in
foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of
Regulation (EC) No 1332/2008 on food enzymes.
Three applications have been introduced by the company ‘Novozymes A/S’ for the authorisation of
the food enzymes Lysophospholipase produced by a genetically modified strain of Aspergillus niger
(strain NZYM-LP), Phospholipase from a genetically modified strain of Aspergillus oryzae (strain NZYM-
PP) and Maltogenic amylase from a genetically modified strain of Bacillus subtilis (strain NZYM-OC),
and one application by the company ‘Puratos NV sa’ for the authorisation of the food enzyme
aqualysin 1 from a genetically modified strain of Bacillus subtilis (strain LMGS 25520).
Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/20113
implementing Regulation (EC) No 1331/2008, the Commission has verified that the four applications
fall within the scope of the food enzyme Regulation and contain all the elements required under
Chapter II of that Regulation.
1 Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and
Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/
112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7–15.
2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, p. 1–6.
3 Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European
Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food
flavourings. OJ L 64, 11.3.2011, p. 15–24.
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1.1.2. Terms of Reference
The European Commission requests the European Food Safety Authority to carry out the safety
assessments of the food enzymes Lysophospholipase produced by a genetically modified strain of
Aspergillus niger (strain NZYM-LP), Phospholipase from a genetically modified strain of Aspergillus
oryzae (strain NZYM-PP), Maltogenic amylase from a genetically modified strain of Bacillus subtilis
(strain NZYM-OC) and aqualysin 1 from a genetically modified strain of Bacillus subtilis (strain LMGS
25520) in accordance with Article 17.3 of Regulation (EC) No 1332/2008 on food enzymes.
1.2. Interpretation of the Terms of Reference
The present scientific opinion addresses the European Commission’s request to carry out the safety
assessment of the food enzyme aqualysin 1 from the genetically modified Bacillus subtilis strain LMGS
25520.
1.3. Information on existing authorisations and evaluations
The French food authorities have evaluated and authorised the use of the food enzyme from the
genetically modified Bacillus subtilis strain LMGS 25520 for food manufacturing processes.
2. Data and methodologies
2.1. Data
The applicant submitted a dossier in support of the application for authorisation of the food enzyme
aqualysin 1 produced with genetically modified Bacillus subtilis strain LMGS 25520. The food enzyme is
intended to be used in baking processes.
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA ‘Guidance on
transparency in the scientific aspects of risk assessment’ (EFSA, 2009b) and following the relevant
existing guidances from the EFSA Scientific Committee.
The current ‘Guidance on the submission of a dossier for safety evaluation of a food enzyme’
(EFSA, 2009a) has been followed for the evaluation of this application with the exception of the
exposure assessment, which was carried out in accordance with the methodology described in the
‘CEF Panel statement on the exposure assessment of food enzymes’ (EFSA CEF Panel, 2016).
3. Assessment
3.1. Technical data
3.1.1. Identity of the food enzyme
IUBMB nomenclature: Aqualysin 1
Systematic name: –
Synonyms: Caldolysin; AQN
IUBMB No: EC 3.4.21.111
CAS No: 88747-68-6
EINECS No: Not available
3.1.2. Chemical parameters
The aqualysin 1 peptidase produced with the genetically modified B. subtilis strain LMGS 25520 is
initially synthesised as a single polypeptide of . The enzyme is secreted and activated
by cleavage of N- and C-terminal sequences, resulting in a functional enzyme of
(calculated molecular mass ). The sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) pattern showed one main protein band and confirmed the molecular mass.
The food enzyme was tested for a-amylase and xylanase activities, which were below the limits of
detection of the applied assays. No other enzymatic activities have been reported by the applicant.
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Data on the chemical parameters of the food enzyme were provided for three batches used for
commercialisation and three batches used for the toxicological tests (Table 1). The average total
organic solids (TOS) of the three food enzyme batches for commercialisation was 5.0%; the values
ranged from 4.62% to 5.42%.
The average enzyme activity/mg TOS ratio of the three food enzyme batches for commercialisation
was 0.063 aqualysin 1 Units/mg TOS; the values ranged from 0.046 to 0.083 U/mg TOS (Table 1).
The food enzyme complies with the specification for lead (not more than 5 mg/kg) as laid down in
the general specifications and considerations for enzymes used in food processing (FAO/WHO, 2006).
In addition, the applicant provided data demonstrating that the levels of arsenic, cadmium and
mercury were below the limits of detection of the employed methodologies.
No antimicrobial activity was detected in any of these batches (FAO/WHO, 2006).
The food enzyme complies with the microbiological criteria as laid down in the general
specifications and considerations for enzymes used in food processing (FAO/WHO, 2006), which
stipulate that Escherichia coli and Salmonella species are absent in 25 g of sample and total coliforms
are not more than 30 colony forming units (CFU) per gram.
The applicant has provided information on the identity of the antifoam agent used. Taking into
account the nature and properties of the antifoam agent, the manufacturing process and the quality
assurance system implemented by the applicant, the Panel considers its use as of no safety concern.
The compositional data provided for the food enzyme batches are considered sufficient.
3.1.3. Properties of the food enzyme
The food enzyme aqualysin 1 is an alkaline serine peptidase, which catalyses the hydrolysis of
peptide bonds in proteins resulting in the generation of polypeptides of different lengths.
The aqualysin 1 peptidase activity is determined based on the hydrolysis of the substrate
N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide and is expressed in Protease Units/mL (U/mL). The analytical
principle is based on the hydrolysis of the substrate, resulting in the release of the yellow p-nitroaniline
(reaction conditions: pH 7.5, temperature 70°C, reaction time 20 min). The concentration of released
p-nitroaniline is determined spectrophotometrically at 415 nm. One unit of protease is defined as the
amount of enzyme that liberates 1.9 lmole of 4-nitroaniline per minute from a 1.02 mM N-succinyl-
Ala-Ala-Pro-Phe p-nitroanilide solution at pH 7.5 and 70°C. The assay includes a pre-incubation of the
food enzyme for 90 min at 70°C in the reaction buffer.
The aqualysin 1 has been characterised regarding its activity depending on temperature and pH.
The pH profile has been measured within a pH range of 4.5–10.5 at 30–80°C; the enzyme is active up
to pH 10.5 with an optimum of 9.5 at 70°C. The temperature profile has been measured from 30 up to
80°C at pH 4.5 to 10.5 and the aqualysin 1 is active at temperatures up to 80°C with an optimum of
70°C at pH 9.5. The aqualysin 1 shows approximately 97% residual activity after incubation for
250 min at 70°C. The stability of the enzyme decreases at temperatures above 70°C, showing only
approximately 5.3% residual activity after 250 min of incubation at 80°C, and no residual activity after
25 min at 90°C.
Table 1: Compositional data of the food enzyme
Parameter Units
Batches
1 2 3 4(a) 5(b) 6(c)
Aqualysin 1 activity U/mL batch(d) 2.83 4.12 2.49 1.51 3.03 31.1
Protein % 1.43 2.71 2.89 NA(f) NA(f) 5.83
Ash % 0.76 0.75 0.86 3.13 0.59 4.36
Water % 94.62 94.29 93.72 94.79 96.57 71.78
Total organic solids (TOS)(e) % 4.62 4.96 5.42 2.08 2.84 23.86
Aqualysin 1 activity/mg TOS U/mg TOS 0.061 0.083 0.046 0.073 0.107 0.130
(a): Batch used for bacterial reverse mutation test.
(b): Batch used for chromosomal aberration test.
(c): Batch used for the repeated dose 14-day and 90-day oral toxicity study (batch after concentration).
(d): U/mL: Protease Unit/mL (see Section 3.3).
(e): TOS calculated as 100% - % water - % ash.
(f): NA: not analysed.
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3.1.4. Information on the source material
3.1.4.1. Information on the genetically modified microorganism
The aqualysin 1 production strain B. subtilis LMGS 25520 is deposited in the Belgian Co-ordinated
Collection of Microorganisms (BCCM/LMG – Bacterial Culture Collection) located at the University of Gent,
under deposit number LMGS 25520.
3.1.4.2. Characteristics of the parental and recipient microorganisms
The parental microorganism is the bacterium B. subtilis, strain
3.1.4.3. Characteristics of the donor organisms
The donor for the aqualysin 1 peptidase gene is the thermophilic bacterium
3.1.4.4. Description of the genetic modification process
The production strain B. subtilis LMGS 25520 was developed by
3.1.4.5. Safety aspects of the genetic modification
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3.1.5. Manufacturing process
The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No 852/20044
and in accordance with current Good Manufacturing Practice (GMP).
The food enzyme is produced by a pure culture of B. subtilis strain LMGS 25520 in a contained,
submerged, fed-batch fermentation system with conventional process controls in place.
After completion of the fermentation, the cells of the B. subtilis LMGS 25520 production strain are
separated from the culture medium by microfiltration. The aqualysin 1 present in the filtrate is
subsequently concentrated by ultrafiltration. Formulation into food enzyme preparation involves spray-
drying after addition of
The absence of the production microorganism in the food enzyme was demonstrated in
The agar medium
used allowed screening for the presence of the production strain. All samples were tested in triplicate.
Recombinant DNA was detected in three food enzyme batches, tested in triplicate, by PCR-analysis
amplifying a fragment of about representing the complete aqualysin 1 coding sequence.
The Panel considered the information provided on the manufacturing process as sufficient.
3.1.6. Safety for the environment
The production strain could not be detected in the food enzyme. However, recombinant DNA was
demonstrated to be present in all batches tested (see Section 3.1.5) (EFSA GMO Panel, 2011). The
applicant provided laboratory transformation tests with samples from production batches were
negative and argued that presence of recombinant DNA was therefore not a concern. However, the
CEF Panel did not consider these laboratory-based data as relevant for the risk assessment.
On the other hand, no sequences that cause safety concern (such as antibiotic resistance genes or
genes encoding known toxins) have been introduced in the production strain, therefore the Panel is of
the opinion that the recombinant DNA present in the food enzyme does not pose a risk to the
environment.
3.1.7. Case of need and intended conditions of use
The food enzyme is intended to be used in baking processes at a recommended use level of up to
190 mg TOS/kg flour.
The food enzyme aqualysin 1 is added to the raw materials during the preparation of dough. It is
used to hydrolyse gluten proteins (glutenin, gliadin), thus contributing to reduce the viscosity, increase
the extensibility and improve the structure of the dough. This results in better processability of the
dough and in more uniform products.
4 Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives.
OJ L 226, 25.6.2004, p. 3–21.
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3.1.8. Reaction and fate in food
Aqualysin 1 catalyses the hydrolysis of peptide bonds in proteins. It is specific in its action, not
known to catalyse other reactions than hydrolysis of peptide bonds in proteins resulting in the
generation of polypeptides of different lengths. Such reaction products are naturally present in protein-
containing foods.
Owing to the substrate specificity of aqualysin 1, no unintended reaction products in foods are to
be expected under the proposed conditions of use. In addition, the information and data provided
indicate that aqualysin 1 is inactivated during processing under the intended use conditions.
3.2. Dietary exposure
Exposure estimates were calculated using the methodology described in the CEF Panel statement
on the exposure assessment of food enzymes (EFSA CEF Panel, 2016). The assessment of the food
process covered in this opinion involved the selection of relevant food groups and the application of
process and technical conversion factors (Appendix B). These input data were subject to a stakeholder
consultation through open calls,5 and adjusted in accordance with feedback received.
3.2.1. EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (hereafter the EFSA
Comprehensive Database6) has been populated with detailed national data on food consumption.
Competent authorities in European countries provide EFSA with data regarding the level of food
consumption by individual consumers, as taken from the most recent national dietary survey in their
country (EFSA, 2011a).
The food consumption data gathered by EFSA were collected using different methodologies and
thus direct country-to-country comparisons should be made with caution. Depending on the food
category and the level of detail used in exposure calculations, uncertainties might be introduced owing
to subjects possibly underreporting and/or misreporting of consumption amounts. Nevertheless, the
EFSA Comprehensive Database is the best available source of food consumption data across Europe.
Food consumption data from the population groups, infants, toddlers, children, adolescents, adults
and the elderly, were used for the exposure assessment. For the present assessment, food consumption
data were available from 33 different dietary surveys carried out in 19 European countries (Appendix A).
Consumption records were codified according to the FoodEx classification system (EFSA, 2011b).
3.2.2. Exposure assessment methodology
Chronic exposure was calculated based on individual consumption from the Comprehensive
Database, averaged over the total survey period, excluding surveys with only one day per subject.
High-level exposure/intake was calculated for only those population groups in which the sample size
was sufficiently large to allow calculation of the 95th percentile (EFSA, 2011a).
The exposure per FoodEx category was subsequently added to derive an individual total exposure per
day. Finally, these exposure estimates were averaged over the number of survey days and normalised for
individual body weight (bw), resulting in an individual average exposure/day per kg bw for the survey
period. This was done for all individuals in the survey and per age class, resulting in distributions of
individual average exposure per survey and age class. Based on these distributions, the mean and 95th
percentile exposures were calculated per survey for the total population and per age class.
3.2.3. Exposure to food enzyme–TOS according to the intended use proposed by
the applicant
Exposure to the food enzyme–TOS was based on intended use and the recommended maximum
use levels of the food enzyme–TOS provided by the applicant (190 mg TOS/kg flour). Food enzyme–
TOS exposure was calculated from foods produced using a baking process.
Relevant food groups and/or individual foods were selected from the Comprehensive Database and
were assumed to always contain the food enzyme–TOS at the maximum recommended use level. This
will result in an overestimation of exposure to food enzyme–TOS.
5 http://www.efsa.europa.eu/en/data/call/161110
6 http://www.efsa.europa.eu/en/food-consumption/comprehensive-database
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To facilitate matching of the reported use levels for baking processes with foods identified in the
Comprehensive Database, the selected foods were disaggregated to ingredient level as appropriate,
and converted into the corresponding raw material, i.e. flour, via the application of conversion factors
(Appendix B). For example, consumption of 100 g of bread was converted into an intake of 70 g flour
(recipe fraction of 0.7) and then multiplied by 190 mg TOS/kg flour, as provided by the applicant, to
arrive at an exposure of 13.3 mg TOS/100 g bread.
Exposure to the food enzyme–TOS was calculated by multiplying values reported for each food
category by their respective consumption amount per kilogram of body weight (kg bw) separately for
each individual in the database. Table 2 provides an overview of the derived exposure estimates.
Average and 95th percentile exposure to the food enzyme-TOS per age class, country and survey are
reported in Appendix C – Table 1. The contribution of the food enzyme–TOS from each FoodEx
category to the total dietary exposure is indicated in Appendix C – Table 2.
3.2.4. Uncertainty analysis
In accordance with the guidance provided in the EFSA Opinion related to uncertainties in dietary
exposure assessment (EFSA, 2007), the following sources of uncertainties have been considered and
are summarised in Table 3.
Table 2: Summary of estimated dietary exposure to food enzyme–TOS in six population groups
Estimated exposure (mg/kg bw per day)
Population
group Infants Toddlers Children Adolescents Adults
The
elderly

































Table 3: Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate
Sources of uncertainties
Direction of impact
Exposure to food enzyme–TOS
Model input data
Consumption data: different methodologies/representativeness/
underreporting/misreporting/no portion size standard
+/
Use of data from food consumption survey of a few days to estimate
long-term (chronic) exposure for high percentiles (95th percentile)
+
Possible national differences in categorisation and classification of food +/
Model assumptions and factors
FoodEx categories included in the exposure assessment were assumed
to always contain the food enzyme–TOS
+
Exposure to food enzyme–TOS was always calculated based on the
recommended maximum use level
+
Selection of broad FoodEx categories for the exposure assessment +
Use of recipe fractions in disaggregation FoodEx categories likely to
contain the food enzyme
+/
Use of technical factors in the exposure model +/
TOS: total organic solids.
+: uncertainty with potential to cause overestimation of exposure; : uncertainty with potential to cause underestimation of
exposure.
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The conservative approach applied to the exposure estimate to food enzyme–TOS, in particular,
assumptions made regarding the occurrence and use levels of this specific food enzyme, is likely to
have led to a considerable overestimation of the exposure.
3.3. Toxicological data
The Panel considered the test items used for the in vitro genotoxicity tests (Table 1, batches 4 and 5)
as representative of the commercial food enzyme (Table 1, batches 1–3).
Batch 6 (Table 1) has been used for the repeated dose oral toxicity studies. It is a concentrate of
the food enzyme prepared by the applicant to achieve a high dose within the volume limitations of a
gavage study.
The aqualysin 1 activity (U/mL) of batch 6 is approximately 10 times higher than the average
activity (U/mL) of the three commercial batches presented in Table 1. In contrast, the TOS content is
increased upon concentration by only a factor of approximately 5, with the consequence that the
activity/mg TOS in batch 6 is approximately twice as high as the average activity/mg TOS of the
commercial batches.
This indicates that the employed concentration procedure did not only result in the loss of water
but apparently also led to a loss of TOS constituent(s). Information on the part of the TOS that has
been removed is not available.
On the other hand, there is also variability between the activities/mg TOS in the commercial
batches. For example, the values for batches 2 and 3 differ by a factor of approximately two. This is
comparable to the difference between the activity/mg TOS between batch 6 and the average of the
commercial batches.
Therefore, the Panel considered batch 6 as acceptable to be used in the feeding study, however
the Panel noted that uncertainties regarding the composition of TOS in this food enzyme concentrate
remain.
3.3.1. Genotoxicity
3.3.1.1. Bacterial reverse mutation test
To investigate the potential of aqualysin 1 to induce gene mutations in bacteria, a bacterial reverse
mutation assay (Ames test) was performed according to OECD Test Guideline 471 (OECD, 1997a) and
following Good Laboratory Practice (GLP). Five strains of Salmonella Typhimurium (TA 97a, TA 98, TA
100, TA 102 and TA 1535) were used in the presence or absence of metabolic activation (S9-mix),
applying plate incorporation method. The highest test sample concentration was also tested using the
spot procedure. Two experiments were carried out using five different concentrations: 50, 160, 500,
1,600 and 5,000 lg food enzyme/plate, corresponding to 1.04, 3.33, 10.4, 33.3 and 104 lg TOS/plate,
appropriate positive controls and sterile water as a negative control. All positive controls induced
significant increases in revertant colony numbers, confirming the sensitivity of the tests and the efficacy
of the S9-mix. The spot tests showed no zone of increased reversion or of toxicity. Due to cytotoxicity
to strain TA 100, no analysis could be performed in the first experiment with metabolic activation (at
concentrations of 160, 500, 1,600 and 5,000 lg food enzyme/plate). Therefore, in the second
experiment six additional concentrations (0.5, 1.6, 5, 16, 50 and 160 lg food enzyme/plate,
corresponding to 0.01, 0.03, 0.10, 0.33, 1.04 and 3.33 lg TOS/plate) were tested with S9-mix in strain
TA 100. Upon treatment with the food enzyme, there was no increase in revertant colony numbers
above control values in any of the strains, with or without metabolic activation.
The Panel concluded that the food enzyme aqualysin 1 did not induce gene mutations in the
bacterial reverse mutation assay under the test conditions employed for this study.
3.3.1.2. In vitro mammalian chromosomal aberration test
The in vitro mammalian chromosomal aberration test was carried out in Chinese Hamster Ovary
(CHO) cells according to OECD Test Guideline 473 (OECD, 1997b) and following GLP. Two experiments
were performed. In the first experiment, applying a short treatment, duplicate cultures were exposed to
the food enzyme for 4 h in the presence and absence of S9-mix, followed by 18 h recovery period. The
following concentrations were tested: 500, 1,000 and 1,500 lg food enzyme/mL in the presence of S9-
mix (corresponding to 14.2, 28.4 and 42.6 lg TOS/mL) and 200, 300 and 500 lg food enzyme/mL in the
absence of the S9-mix (corresponding to 5.7, 8.5 and 14.2 lg TOS/mL). In the second experiment, two
treatment conditions were applied: (i) continuous treatment (18 + 0 h), where cultures were exposed to
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the food enzyme for 18 h without S9-mix at 750, 1,000 and 1,500 lg food enzyme/mL (corresponding to
21.3, 28.2 and 42.6 lg TOS/mL) and (ii) short treatment in the presence of S9-mix at 1,000, 1,300 and
2,000 lg food enzyme/mL (corresponding to 28.2, 36.2 and 56.8 lg TOS/mL). Two hundred
metaphases were scored per experimental point. The reductions in mitotic index did not exceed 41% of
negative control values at any concentration of food enzyme tested. The frequency of chromosomal
aberrations in treated cultures was comparable to the values detected in negative controls and within the
range of the laboratory historical solvent control data. A statistically significant increase in
endoreduplicated cells was observed after short treatment in the presence of S9-mix together with
a dose-related decrease of mitotic index up to 50% of negative control values; based on the OECD
TG 473 (2014) the increase in the endoreduplicated cells is possibly due to cell cycle perturbation or
cytotoxicity. The positive controls induced a significant increase in the frequency of cells with structural
chromosomal aberrations. The Panel concluded that the food enzyme aqualysin 1 did not induce
chromosomal damage in CHO cells under the test conditions employed for this study.
3.3.2. Subchronic toxicity
3.3.2.1. Repeated dose 14-day oral toxicity study
A repeated dose 14-day oral toxicity study in rodents was performed as a dose range finding study
to evaluate the potential toxicity of the food enzyme following daily oral gavage for a further repeated
dose 90-day oral toxicity study to be performed in the same species. GLP was not claimed.
Three groups of three male and three female Sprague–Dawley rats (Crl CD(SD)IGS BR) received
the food enzyme (batch 6) at the dose levels of 36.3, 145.1 or 290.1 U/kg bw per day, under a
dosage-volume of 1.17, 4.67 or 9.33 mL/kg bw per day (referred to as low, mid and high dose) by oral
gavage for 2 weeks. These doses correspond to 279, 1,116 and 2,232 mg TOS/kg bw per day. The
control group received water by gavage at a constant dosage-volume of 9.33 mL/kg bw per day. The
test item was provided as ‘ready-to-use’ dosage form with an enzymatic activity of 31.1 U/mL.
One high-dose female was sacrificed on day 10 for ethical reasons, showing the following clinical
signs: hunched posture, piloerection, thin appearance, coldness to the touch, hypoactivity, ventral
recumbency, tremors, abdominal breathing, half-closed eyes and soiled areas. A slight body weight
loss, associated with a low food intake was recorded between days 4 and 8. At necropsy, black
discoloration of the thymus and red discoloration in the lungs were observed in this animal.
No statistically significant differences in body weight and food intake were observed between
control and all other exposed animals. A lower body weight gain (48%) and a slightly lower food
consumption (14%) were recorded in high-dose males between days 1 and 4 but these findings
were without effect on final mean body weight.
In high-dose animals hypersalivation (in all animals) was observed from the first week of treatment
period. Piloerection (3/3 males, 2/3 females), hypoactivity (2/3 males), dyspnoea (3/3 males), soiled
areas (2/3 males) and hunched posture (1/3 males and 1/3 females) appeared during the second
week of the treatment period.
In the mid-dose group, hypersalivation (in all animals) occurred from the first week of treatment
period and piloerection (in almost all animals) from day 10, dyspnoea (2/3 males on days 10 or 11, 1/3
females on days 10 and 11) and hunched posture (1/3 females from day 13).
In the low-dose group, only piloerection (1/3 males) from day 10 and hypersalivation (1/3 males)
from day 14 were recorded. No clinical signs were observed in females.
In the control group no clinical signs and pathological–anatomical changes were observed.
Based on the above results the applicant selected the low dose of this range finding study as high
dose for the repeated dose 90-day oral toxicity study.
3.3.2.2. Repeated dose 90-day oral toxicity study in rodents
A repeated dose 90-day oral toxicity study in rodents was performed in accordance with OECD Test
Guideline 408 (OECD, 1998) and following GLP. Three groups of 10 male and 10 female Sprague–
Dawley rats received the food enzyme (batch 6) at the dose levels of 12.8, 25.6 and 38.4 U/kg bw per
day (referred to as low, mid and high dose) by oral gavage. These doses correspond to 98.5, 197 and
295 mg TOS/kg bw per day. The control group received water by gavage under a constant dosage-
volume of 1.23 mL/kg bw per day.
There were no premature deaths or unscheduled sacrifices during the study, except for a single low
dose female, sacrificed prematurely on week 13 after blood sampling.
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Moderate increases in the mean body weights and relative body weight gains of food enzyme-
treated females were observed from week 2 up to week 11. No clear dose relationship was observed
and these changes did not correlate with changes in food intake.
During the 13-week treatment period, mainly dose-related hypersalivation was observed in food
enzyme-treated groups in both sexes. Increased incidence of fur and skin staining was observed in all
food enzyme-treated female groups. These observations appeared to be associated with the delivery
of the food enzyme but were considered as non-adverse.
Blood biochemistry investigations at the end of the treatment period showed minimally lower
inorganic phosphorus levels in high-dose females (13%), and minimally elevated levels of creatinine
(9%) in mid- and high-dose females. A trend towards an increase was observed in aspartate
aminotransferase activity in mid- and high-dose (22%) males. The values are within the historical
control range and not considered adverse.
No effects on food intake, ophthalmological findings, haematology, functional observation battery
tests, organ weight, macroscopic or microscopic evaluations were observed. It was concluded that
under the conditions of this repeated dose 90-day oral toxicity study the NOAEL is 38.4 U/kg bw per
day, corresponding to 295 mg TOS/kg bw per day.
A comparison of the NOAEL (295 mg TOS/kg bw per day) from the 90-day study with the derived
dietary exposure estimates of 0.521–1.134 mg/kg bw per day at the mean and 0.975–2.132 mg TOS/kg
bw per day at the 95th percentile, resulted in a margin of exposure (MOE) of 138.
3.4. Allergenicity
The allergenicity assessment considers only the food enzyme and not any carrier or other excipient
which may be used in the final formulation.
The allergenicity of aqualysin 1 produced with the genetically modified B. subtilis strain LMGS
25520 has been assessed by comparison of its amino acid sequence with those of known allergens,
according to the EFSA Scientific opinion on the assessment of allergenicity of GM plants and
microorganisms and derived food and feed of the Scientific Panel on Genetically Modified Organisms
(EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino acids as
criterion 23 matches were found, of which 20 matched with respiratory allergens (mainly fungal
allergens) and 3 matched with dermal allergens.
Several cases of respiratory allergy following occupational inhalation of aerosols containing
proteases or other enzymes have been reported (Martel et al., 2010). However, aqualysin 1 from
B. subtilis strain LMGS 25520 is not described as an allergen and no food allergic reactions to this food
enzyme have been reported. Although 20 of the matches found were with mainly occupational
respiratory fungal allergens, several studies have shown that patients with occupational asthma to a
food enzyme (e.g. a-amylase) can commonly ingest the corresponding enzyme without acquiring
clinical symptoms of food allergy (Cullinan et al., 1997; Brisman, 2002; Poulsen, 2004; Armentia et al.,
2009). The match with the three dermal allergens is not relevant in respect to the ingestion of the
food enzyme as protein based dermal allergies (atopic dermatitis) are mainly triggered by respiratory
exposure. Therefore there is no indication for potential allergenicity of the food enzyme aqualysin 1.
The cross-reactivity of food enzymes was studied by Bindslev-Jensen et al. (2006). There were no
indications of cross-reactivity upon oral exposure to 19 tested food enzymes and the main allergens
represented by the 400 patients (allergic to inhalation allergens, food allergens, allergens of bee or
wasp) included in this study.
Taken together, the CEF Panel considers that there are no indications for food allergic reactions by
dietary exposure to aqualysin 1 produced with B. subtilis strain LMGS 25520.
Conclusions
The genetic modifications performed, the manufacturing process, the compositional and
biochemical data, the dietary exposure, as well as the allergenicity and the genotoxicity assessment
did not raise safety concerns.
The Panel considered the MOE calculated from the NOAEL determined from the repeated dose
90-day oral toxicity study and the estimated dietary exposure as insufficient to conclude that there is
no safety concern for this food enzyme under the intended conditions of use.
The Panel noted that recombinant DNA was demonstrated to be present in all batches of the food
enzyme tested.
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Documentation provided to EFSA
1) ‘Application for authorisation of Aqualysin 1 with a genetically modified strain of Bacillus
subtilis in accordance with Regulation (EC) No 1331/2008’. November 2014. Submitted by
Puratos NV.
2) Summary reports on technical, toxicological and genetic modifications data were delivered by
Hylobates Consulting/BiCT (Rome, Italy) on 22 February 2016, FoBiG GmbH (Freiburg,
Germany) on 22 February 2015 and by the Technical University of Denmark (Søborg,
Denmark) on 9 September 2015, respectively.
3) Additional information received from Puratos NV in March 2015.
4) Additional information received from Puratos NV in August 2017.
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Abbreviations
bw body weight
BCCM Belgian Co-ordinated Collection of Microorganisms
CAS Chemical Abstracts Service
CFU colony forming units
CHO Chinese Hamster Ovary
EC Enzyme Commission
EINECS European Inventory of Existing Commercial Chemical Substances
FAO Food and Agricultural Organization
GLP Good Laboratory Practice
GMO genetically modified organisms
GMP Good Manufacturing Practice
IUBMB International Union of Biochemistry and Molecular Biology
JECFA Joint FAO/WHO Expert Committee on Food Additives
MIC minimum inhibitory concentration
MOE margin of exposure
NOAEL no observed adverse effect level
OECD Organisation for Economic Cooperation and Development
PCR polymerase chain reaction
RNA ribonucleic acid
SDS–PAGE sodium dodecyl sulfate–polyacrylamide gel electrophoresis
QPS Qualified Presumption of Safety
TOS total organic solids
WHO World Health Organization
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Appendix A – Population groups considered for the exposure assessment
Population Age range
Countries with food consumption surveys
covering more than one day
Infants From 12 weeks on up to and
including 11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, United Kingdom
Toddlers From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy,
Netherlands, Spain, United Kingdom
Children(a) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland,
France, Germany, Greece, Italy, Latvia, Netherlands, Spain,
Sweden, United Kingdom
Adolescents From 10 years up to and
including 17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland,
France, Germany, Italy, Latvia, Spain, Sweden, United
Kingdom
Adults From 18 years up to and
including 64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania,
Spain, Sweden, United Kingdom
The elderly(a) From 65 years of age and older Austria, Belgium, Denmark, Finland, France, Germany, Hungary,
Ireland, Italy, Romania, Sweden, United Kingdom
(a): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a).
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Appendix B – FoodEx categories used to derive exposure estimates for the
food enzyme–TOS and the respective conversion factors










A.01 Grains and grain-based products (unspecified) 0.8 1 190
A.01.03 Grain milling products (unspecified) 1 1 190
A.01.03.001 Wheat milling products (unspecified) 1 1 190
A.01.03.001.001 Wheat flour, brown 1 1 190
A.01.03.001.002 Wheat flour, Durum 1 1 190
A.01.03.001.003 Wheat flour, white 1 1 190
A.01.03.001.004 Wheat flour, wholemeal 1 1 190
A.01.03.001.005 Graham flour 1 1 190
A.01.03.001.006 Wheat flour, gluten free 1 1 190
A.01.03.001.014 Wheat starch 1.2 1 190
A.01.03.002 Rye milling products (unspecified) 1 1 190
A.01.03.002.001 Rye flour, gluten free 1 1 190
A.01.03.002.002 Rye flour, light 1 1 190
A.01.03.002.003 Rye flour, medium 1 1 190
A.01.03.002.004 Rye flour, wholemeal 1 1 190
A.01.03.003 Buckwheat milling products (unspecified) 1 1 190
A.01.03.003.001 Buckwheat flour 1 1 190
A.01.03.004 Corn milling products (unspecified) 1 1 190
A.01.03.004.001 Corn flour 1 1 190
A.01.03.004.003 Corn starch 1.3 1 190
A.01.03.005 Oat milling products (unspecified) 1 1 190
A.01.03.005.002 Oat flour 1 1 190
A.01.03.005.004 Oat starch 1.2 1 190
A.01.03.006 Rice milling products (unspecified) 1 1 190
A.01.03.006.001 Rice flour 1 1 190
A.01.03.006.002 Rice flour white 1 1 190
A.01.03.006.003 Rice flour, instant 1 1 190
A.01.03.006.004 Rice starch 1.2 1 190
A.01.03.007 Spelt milling products 1 1 190
A.01.03.008 Other milling products (unspecified) 1 1 190
A.01.03.008.001 Amaranth flour 1 1 190
A.01.03.008.002 Barley flour 1 1 190
A.01.03.008.003 Chapatti flour 1 1 190
A.01.03.008.004 Flour mix, wheat/rye/barley/oats 1 1 190
A.01.03.008.005 Millet flour 1 1 190
A.01.03.008.007 Sorghum flour 1 1 190
A.01.04 Bread and rolls (unspecified) 1 0.7 190
A.01.04.001 Wheat bread and rolls 1 0.7 190
A.01.04.002 Rye bread and rolls 1 0.7 190
A.01.04.003 Mixed wheat and rye bread and rolls 1 0.7 190
A.01.04.004 Multigrain bread and rolls 1 0.7 190
A.01.04.005 Unleavened bread, crisp bread and rusk
(unspecified)
1 0.8 190
A.01.04.005.001 Crisp bread, rye wholemeal 1 0.9 190
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A.01.04.005.002 Crisp bread, rye, light 1 0.9 190
A.01.04.005.003 Crisp bread, wheat, wholemeal 1 0.9 190
A.01.04.005.004 Crisp bread, wheat, light 1 0.9 190
A.01.04.005.005 Rusk, light 1 0.9 190
A.01.04.005.006 Rusk, wholemeal 1 0.9 190
A.01.04.005.007 Pita bread 1 0.7 190
A.01.04.005.008 Matzo 1 0.9 190
A.01.04.005.009 Tortilla 1 0.7 190
A.01.04.006 Other bread 1 0.7 190
A.01.04.007 Bread products 1 0.7 190
A.01.07 Fine bakery wares (unspecified) 1 0.5 190
A.01.07.001 Pastries and cakes (unspecified) 1 0.5 190
A.01.07.001.001 Beignets 1 0.15 190
A.01.07.001.002 Buns 1 0.7 190
A.01.07.001.003 Cake from batter 1 0.25 190
A.01.07.001.004 Cheese cream cake 1 0.24 190
A.01.07.001.005 Cheese cream sponge cake 1 0.24 190
A.01.07.001.006 Chocolate cake 1 0.24 190
A.01.07.001.007 Chocolate cake with fruits 1 0.24 190
A.01.07.001.008 Cream cake 1 0.24 190
A.01.07.001.009 Cream cheese cake 1 0.24 190
A.01.07.001.010 Cream custard cake 1 0.24 190
A.01.07.001.011 Cream custard sponge cake 1 0.24 190
A.01.07.001.012 Croissant 1 0.5 190
A.01.07.001.013 Croissant, filled with chocolate 1 0.5 190
A.01.07.001.014 Croissant, filled with cream 1 0.5 190
A.01.07.001.015 Croissant, filled with jam 1 0.5 190
A.01.07.001.016 Croquembouche 1 0.15 190
A.01.07.001.017 Doughnuts 1 0.24 190
A.01.07.001.018 Clair 1 0.15 190
A.01.07.001.019 Flan 1 0.5 190
A.01.07.001.020 Fruit cake 1 0.6 190
A.01.07.001.021 Fruit pie 1 0.15 190
A.01.07.001.022 Cheese pie 1 0.15 190
A.01.07.001.023 Fruit tart 1 0.15 190
A.01.07.001.024 Gingerbread 1 0.6 190
A.01.07.001.025 Gougere 1 0.15 190
A.01.07.001.026 Kringles 1 0.25 190
A.01.07.001.027 Nut cream cake 1 0.24 190
A.01.07.001.028 Pancakes 1 0.25 190
A.01.07.001.029 Profiterole 1 0.15 190
A.01.07.001.030 Pyramid cake 1 0.25 190
A.01.07.001.031 Rhubarb flan 1 0.15 190
A.01.07.001.032 Scone 1 0.5 190
A.01.07.001.033 Sponge dough 1 0.25 190
A.01.07.001.034 Sponge cake 1 0.25 190
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A.01.07.001.035 Sponge cake roll 1 0.25 190
A.01.07.001.036 Muffins 1 0.25 190
A.01.07.001.037 Waffles 1 0.25 190
A.01.07.001.038 Apple strudel 1 0.15 190
A.01.07.001.039 Cream-cheese strudel 1 0.24 190
A.01.07.001.040 Cheese pastry goods from puff pastry 1 0.15 190
A.01.07.001.041 Croissant from puff pastry 1 0.6 190
A.01.07.001.042 Brioche 1 0.5 190
A.01.07.001.044 Lebkuchen 1 0.6 190
A.01.07.001.045 Dumpling 1 0.5 190
A.01.07.001.046 Cake marbled, with chocolate 1 0.5 190
A.01.07.001.047 Marzipan pie 1 0.25 190
A.01.07.001.048 Baklava 1 0.15 190
A.01.07.002 Biscuits (cookies) 1 0.9 190
A.01.07.002.001 Biscuits, sweet, plain 1 0.9 190
A.01.07.002.002 Biscuits, chocolate filling 1 0.81 190
A.01.07.002.003 Biscuits, cream filling 1 0.81 190
A.01.07.002.004 Biscuits, fruit filling 1 0.81 190
A.01.07.002.005 Biscuits, vanilla filling 1 0.81 190
A.01.07.002.006 Butter biscuits 1 0.81 190
A.01.07.002.007 Biscuit, iced 1 0.81 190
A.01.07.002.008 Speculaas 1 0.9 190
A.01.07.002.009 Biscuits, sweet, wheat wholemeal 1 0.9 190
A.01.07.002.010 Biscuits, oat meal 1 0.9 190
A.01.07.002.011 Biscuits, spelt meal 1 0.9 190
A.01.07.002.012 Biscuits, salty 1 0.9 190
A.01.07.002.013 Biscuits, salty, with cheese 1 0.81 190
A.01.07.002.014 Sticks, salty 1 0.81 190
A.17.03.003 Biscuits, rusks and cookies for children 1 0.9 190
A.18.04.001 Find bakery products for diabetics 1 0.5 190
A.19.01.001 Sandwich and sandwich-like meal 1 0.32 190
A.19.01.002 Pizza and pizza-like pies 1 0.3 190
TOS: total organic solids.
(a): Food and Agriculture Organization of the United Nations. Technical Conversion Factors for Agricultural Commodities. Available
from: http://www.fao.org/economic/the-statistics-division-ess/methodology/methodology-systems/technical-conversion-factors-
for-agricultural-commodities/en/
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Appendix C – Dietary exposure estimates to the food enzyme-TOS in
details
Information provided in this appendix is shown in an excel file (http://onlinelibrary.wiley.com/wol1/
doi/10.2903/j.efsa.2018.5170/suppinfo).
The file contains two sheets, corresponding to two tables.
Table 1: Average and 95th percentile exposure to the food enzyme-TOS per age class, country and
survey
Table 2: The contribution of the food enzyme–TOS from each FoodEx category to the total dietary
exposure
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